Monday's ETF Winners & Losers
The
HealthShares Emerging Cancer
(HHJ)
exchange-traded fund was higher to start the week. Holding
Dendreon
(DNDN)
, which has tripled since late March after the Food and Drug Administration endorsed the company's Provenge prostate cancer vaccine treatment, was climbing another 25%. The ETF was recently up $1.38, or 5.1%, to $28.38.
The
iShares Dow Jones Transportation Average
(IYT) - Get Report
was another of the session's winners. Rail concern
Burlington Northern Santa Fe
(BNI)
jumped after a
Securities and Exchange Commission
filing stated that billionaire investor Warren Buffett's
Berkshire Hathaway
(BRK.A) - Get Report
has purchased a 10.9% stake in the company, making it the largest shareholder.
The ETF was rising by $2.01, or 2.3%, to $90.11.
On the flip side, bundled securities tracking the energy sector were among the worst performers of the day. The front-month May crude contract fell $1.19 to $63.09 a barrel.
The
iPath Goldman Sachs Crude Oil Index
(OIL) - Get Report
ETF eased 2% to $37.22. The
United States Oil
(USO) - Get Report
ETF was recently down 1.9% to $51.04. The
PowerShares DB Oil
(DBO) - Get Report
ETF was recently lower by 1.7% to $26.14.
The
Biotech HOLDRs
(BBH) - Get Report
ETF was also losing ground. Holdings
Amgen
(AMGN) - Get Report
and
Genentech
(DNA)
fell 1%, and Biotech HOLDRs was recently lower by $1.36, or 0.8%, to $178.99.